Cardiovascular Nanomedicine
Seiten
2024
Royal Society of Chemistry (Verlag)
978-1-83767-058-1 (ISBN)
Royal Society of Chemistry (Verlag)
978-1-83767-058-1 (ISBN)
- Noch nicht erschienen (ca. Oktober 2024)
- Versandkostenfrei
- Auch auf Rechnung
- Artikel merken
This book expands on understanding and provides in-depth and insightful discussion on the mechanistic, pre-clinical and clinical applications of nanomedicine in cardiovascular disease.
The integration of nanoparticles with classical drugs to create biocompatible delivery platforms for the treatment of cardiovascular diseases can make a major impact on patient welfare.
Traditional drug delivery systems are not selective and induce severe collateral damage to surrounding non-diseased cells and tissues. Nanoparticles, however, can be bio-conjugated with antibodies to encapsulate cardiovascular drugs, gaseous molecules and biomolecules to selectively deliver them in a safe, targeted and cost-effective manner.
This book provides in-depth and insightful discussion on the mechanistic, pre-clinical and clinical applications of nanomedicine in cardiovascular disease. It not only discusses core chemical concepts via the synthesis of novel nanotechnology-based drug formulations, but also covers the latest drug delivery advances including innovative therapeutic targets in cardiovascular lesions at an early, curable and reversible stage.
Written by experts in the field, students and researchers will find this book equally useful for understanding the trends and challenges of the clinical translation of cardiovascular nanomedicine.
The integration of nanoparticles with classical drugs to create biocompatible delivery platforms for the treatment of cardiovascular diseases can make a major impact on patient welfare.
Traditional drug delivery systems are not selective and induce severe collateral damage to surrounding non-diseased cells and tissues. Nanoparticles, however, can be bio-conjugated with antibodies to encapsulate cardiovascular drugs, gaseous molecules and biomolecules to selectively deliver them in a safe, targeted and cost-effective manner.
This book provides in-depth and insightful discussion on the mechanistic, pre-clinical and clinical applications of nanomedicine in cardiovascular disease. It not only discusses core chemical concepts via the synthesis of novel nanotechnology-based drug formulations, but also covers the latest drug delivery advances including innovative therapeutic targets in cardiovascular lesions at an early, curable and reversible stage.
Written by experts in the field, students and researchers will find this book equally useful for understanding the trends and challenges of the clinical translation of cardiovascular nanomedicine.
Cardiovascular Nanomedicine: From Targeted Delivery to Theranostics
Photoluminescent Nanomaterials for Cardiovascular Diagnosis and Therapeutics
Nanoparticles for the Treatment of Ischemic Heart Diseases
Cardiovascular Nanomedicine: Mode of Action and Applications
Novel Nanotherapies for the Treatment of Coronary Atherosclerosis
Advanced Nanomaterials for Cardiovascular Implants
Bio Ceramics Based Cardiovascular Implants
Targeted Gold Nanotherapy for the Attenuation of Chemotherapy-associated Cardiotoxicity
Extracellular Vesicles for the Treatment of Cardiovascular Diseases
| Erscheint lt. Verlag | 25.10.2024 |
|---|---|
| Reihe/Serie | Nanoscience & Nanotechnology Series ; Volume 64 |
| Verlagsort | Cambridge |
| Sprache | englisch |
| Maße | 156 x 234 mm |
| Gewicht | 575 g |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Kardiologie / Angiologie |
| Naturwissenschaften | |
| Technik | |
| ISBN-10 | 1-83767-058-7 / 1837670587 |
| ISBN-13 | 978-1-83767-058-1 / 9781837670581 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
in Fällen, Fragen und Antworten
Buch | Softcover (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 124,60
Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
CHF 61,60
